These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 31584433)
1. Relationship of serum salusin beta levels with coronary slow flow. Akyüz A; Aydın F; Alpsoy Ş; Ozkaramanli Gur D; Guzel S Anatol J Cardiol; 2019 Sep; 22(4):177-184. PubMed ID: 31584433 [TBL] [Abstract][Full Text] [Related]
2. Serum Salusin-β Levels Are Correlated with Slow Coronary Flow. Wang T; Dong AH; Cao HY Genet Test Mol Biomarkers; 2016 Jul; 20(7):393-7. PubMed ID: 27227272 [TBL] [Abstract][Full Text] [Related]
3. The relationship between coronary slow flow phenomenon and urotensin-II: A prospective and controlled study. Zengin H; Erbay AR; Okuyucu A; Alaçam H; Yüksel S; Meriç M; Soylu K; Gedikli Ö; Murat N; Gülel O; Demircan S; Akın F; Yılmaz Ö; Şahin M Anatol J Cardiol; 2015 Jun; 15(6):475-9. PubMed ID: 25430414 [TBL] [Abstract][Full Text] [Related]
4. Serum salusin-β levels are associated with the presence and severity of coronary artery disease. Liu J; Ren YG; Zhang LH; Tong YW; Kang L J Investig Med; 2015 Apr; 63(4):632-5. PubMed ID: 25730454 [TBL] [Abstract][Full Text] [Related]
5. The relation between coronary flow rate, plasma endothelin-1 concentrations, and clinical characteristics in patients with normal coronary arteries. Celebi H; Catakoglu AB; Kurtoglu H; Sener M; Hanavdelogullari R; Demiroglu C; Aytekin V; Aytekin S Cardiovasc Revasc Med; 2008; 9(3):144-8. PubMed ID: 18606377 [TBL] [Abstract][Full Text] [Related]
6. The importance of circulating levels of salusin-α, salusin-β, and heregulin-β1 in atherosclerotic coronary arterial disease. Arkan A; Atukeren P; Ikitimur B; Simsek G; Koksal S; Gelisgen R; Ongen Z; Uzun H Clin Biochem; 2021 Jan; 87():19-25. PubMed ID: 33031820 [TBL] [Abstract][Full Text] [Related]
7. Serum salusin-α levels are inversely correlated with the presence and severity of coronary artery disease. Du SL; Wang WJ; Wan J; Wang YG; Wang ZK; Zhang Z Scand J Clin Lab Invest; 2013; 73(4):339-43. PubMed ID: 23611255 [TBL] [Abstract][Full Text] [Related]
8. Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow. Ding YD; Pei YQ; Wang R; Yang JX; Zhao YX; Liu XL; Shen H; Ma Q; Zhang S; Ge HL BMC Cardiovasc Disord; 2020 May; 20(1):248. PubMed ID: 32460702 [TBL] [Abstract][Full Text] [Related]
9. Documentation of impaired coronary blood flow by TIMI frame count method in patients with atrial fibrillation. Luo C; Wu X; Huang Z; Du Z; Hao Y; Hu C; Huang Y; Gao X Int J Cardiol; 2013 Aug; 167(4):1176-80. PubMed ID: 22483250 [TBL] [Abstract][Full Text] [Related]
10. Increased high sensitive CRP level and its significance in pathogenesis of slow coronary flow. Barutcu I; Sezgin AT; Sezgin N; Gullu H; Esen AM; Topal E; Ozdemir R; Kosar F; Cehreli S Angiology; 2007; 58(4):401-7. PubMed ID: 17652225 [TBL] [Abstract][Full Text] [Related]
11. Endocan may predict the presence of coronary slow flow and coronary artery disease. Efe MM; Akyüz A; Aydın C; Demirkıran A; Alpsoy Ş Rev Assoc Med Bras (1992); 2024; 70(8):e20240515. PubMed ID: 39230149 [TBL] [Abstract][Full Text] [Related]
12. Coronary blood flow in patients with end-stage renal disease assessed by thrombolysis in myocardial infarction frame count method. Sobkowicz B; Tomaszuk-Kazberuk A; Kralisz P; Malyszko J; Kalinowski M; Hryszko T; Sawicki R; Dobrzycki S; Musial WJ Nephrol Dial Transplant; 2010 Mar; 25(3):926-30. PubMed ID: 19875377 [TBL] [Abstract][Full Text] [Related]
13. Association of paraoxonase activity and coronary blood flow. Yildiz A; Gur M; Yilmaz R; Demirbag R; Polat M; Selek S; Celik H; Erel O Atherosclerosis; 2008 Mar; 197(1):257-63. PubMed ID: 17537444 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of serum salusin-α and β levels in patients with obstructive sleep apnea. Kerget B; Afşin DE; Laloglu E Biomark Med; 2024; 18(13-14):603-610. PubMed ID: 38982740 [TBL] [Abstract][Full Text] [Related]
15. [The association of coronary slow flow with time to peak systolic strain]. Aksakal E; Islamoğlu Y; Simşek Z; Elbey MA; Sevimli S; Arslan S; Gündoğdu F; Senocak H Turk Kardiyol Dern Ars; 2011 Jan; 39(1):29-34. PubMed ID: 21358228 [TBL] [Abstract][Full Text] [Related]
16. Assessment of risk factors and left ventricular function in patients with slow coronary flow. Li Y; Wang Y; Jia D; Lv Y; Zhang Y; Guan Z; Ma C Heart Vessels; 2016 Mar; 31(3):288-97. PubMed ID: 25475386 [TBL] [Abstract][Full Text] [Related]
17. Assessment of triglyceride/glucose index with respect to coronary slow flow. Buber I; Nar R; Kaya D; Senol H; Adali MK; Nar G Bratisl Lek Listy; 2022; 123(8):585-588. PubMed ID: 35852510 [TBL] [Abstract][Full Text] [Related]
18. Assessment of salusin alpha and salusin beta levels in patients with newly diagnosed dipper and non-dipper hypertension. Alpsoy S; Dogan B; Ozkaramanli Gur D; Akyüz A; Fidan Ç; Guzel S; Ozkoyuncu B Clin Exp Hypertens; 2021 Jan; 43(1):42-48. PubMed ID: 32723189 [TBL] [Abstract][Full Text] [Related]
19. Relationship of salusin-alpha and salusin-beta levels with atherosclerosis in patients undergoing haemodialysis. Sipahi S; Genc AB; Acikgoz SB; Yildirim M; Aksoy YE; Vatan MB; Dheir H; Altındis M Singapore Med J; 2019 Apr; 60(4):210-215. PubMed ID: 30311629 [TBL] [Abstract][Full Text] [Related]
20. Associations of serum salusin-alpha levels with atherosclerosis and left ventricular diastolic dysfunction in essential hypertension. Ti Y; Wang F; Wang ZH; Wang XL; Zhang W; Zhang Y; Bu PL J Hum Hypertens; 2012 Oct; 26(10):603-9. PubMed ID: 21833023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]